Phase 3 Study of SNF472 for Calciphylaxis
NCT04195906
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
71
Enrollment
OTHER
Sponsor class
Conditions
Calciphylaxis
Calcific Uremic Arteriolopathy
Interventions
DRUG:
Experimental: SNF472
DRUG:
Placebo Comparator: Placebo
DRUG:
Experimatenl SNF472 (Open-label)
Sponsor
Sanifit Therapeutics S. A.